Hanmi Pharm. Co., Ltd. (128940.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 511,000.00

From 52W high−17.73%

Volume115488.00

Market capKRW 7.41T

P/E (TTM)27.8x

P/S (TTM)4.5x

Div yield0.39%

Key dataSep 18, 2026

Open

KRW 511,000.00

From 52W high

−17.73%

Volume

115488.00

Market cap

KRW 7.41T

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

20.0x

P/E (TTM)

27.8x

RSI (14)

58.7

MomentumView details →

1D Return

+2.59%

YTD Return

+11.28%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

27.8x

EV/EBITDA

20.0x

EV/Sales

4.6x

P/S (TTM)

4.5x

P/B (TTM)

5.3x

ProfitabilityView details →

Gross Margin

59.59%

Net Margin

13.11%

EBITDA Margin

22.94%

ROE (TTM)

15.46%

ROA (TTM)

9.30%

Asset Turnover

0.73x

GrowthView details →

Revenue YoY

+12.93%

EPS YoY

+118.74%

FCF YoY

+134.21%

Revenue CAGR 3Y

+5.14%

EPS CAGR 3Y

+27.07%

EBITDA YoY

+44.11%

MomentumView details →

1D Return

+2.59%

YTD Return

+11.28%

1Y Return

+39.53%

RSI (14)

58.7

vs 50D SMA

+18.22%

vs 200D SMA

+8.20%

Capital & dividendView details →

Debt/Equity

0.30x

Current Ratio

1.82x

Quick Ratio

1.17x

Div Yield

0.39%

Div Rate

KRW 2,000.00

Div Growth 1Y

−80.00%

EarningsView details →

EPS (Actual)

KRW 6,503.01

EPS Surprise

60.09%

Beats (12Q)

1/12

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

60.09%

Rev Surprise

8.46%

Financials snapshotView financials →

Revenue (TTM)

1.66T

Net Income (TTM)

217.04B

Op. CF (TTM)

269.97B

Next earningsOct 29, 2026 →

Latest newsMore news →

No recent news for 128940.KS.

Similar companies

Yuhan Corporation000100.KS Yuhan Corporation000105.KS Hanall Biopharma Co.,Ltd009420.KS Celltrion Pharm, Inc.068760.KQ Daewoong pharmaceutical Co.,Ltd069620.KS JW Pharmaceutical Corporation001067.KS Find similar companies →

Latest newsMore news →

No recent news for 128940.KS.